{"count": 30, "results": [{"_id": "40096893", "pmid": 40096893, "title": "Metformin attenuates myocardial ischemia/reperfusion-induced ferroptosis through the upregulation of Nur77-mediated IDH1.", "journal": "Biochim Biophys Acta Mol Cell Res", "authors": ["Wu Z", "Bai Y", "Chang C", "Jiao Y", "Chen Q", "Guo Z"], "date": "2025-03-15T00:00:00Z", "doi": "10.1016/j.bbamcr.2025.119934", "meta_date_publication": "2025 Mar 15", "meta_volume": "1872", "meta_issue": "4", "meta_pages": "119934", "score": 50256.965, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ attenuates @<m>DISEASE_Myocardial_Ischemia</m> @DISEASE_MESH:D017202 @@@myocardial ischemia@@@/reperfusion-induced ferroptosis through the upregulation of @GENE_NR4A1 @GENE_79240 @@@Nur77@@@-mediated @GENE_IDH1 @GENE_24479 @@@IDH1@@@.", "citations": {"NLM": "Wu Z, Bai Y, Chang C, Jiao Y, Chen Q, Guo Z. Metformin attenuates myocardial ischemia/reperfusion-induced ferroptosis through the upregulation of Nur77-mediated IDH1. Biochim Biophys Acta Mol Cell Res. 2025 Mar 15;1872(4):119934. PMID: 40096893", "BibTeX": "@article{40096893, title={Metformin attenuates myocardial ischemia/reperfusion-induced ferroptosis through the upregulation of Nur77-mediated IDH1.}, author={Wu Z and Bai Y and Chang C and Jiao Y and Chen Q and Guo Z}, journal={Biochim Biophys Acta Mol Cell Res}, volume={1872}, number={4}, pages={119934}}"}}, {"_id": "33232283", "pmid": 33232283, "pmcid": "PMC7762510", "title": "Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway", "journal": "Aging (Albany NY)", "authors": ["Zhang J", "Huang L", "Shi X", "Yang L", "Hua F", "Ma J", "Zhu W", "Liu X", "Xuan R", "Shen Y", "Liu J", "Lai X", "Yu P"], "date": "2020-11-24T00:00:00Z", "doi": "10.18632/aging.202143", "meta_date_publication": "2020 Nov 24", "meta_volume": "12", "meta_issue": "23", "meta_pages": "24270-24287", "score": 50253.547, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ protects against @<m>DISEASE_Myocardial_Ischemia</m> @DISEASE_MESH:D017202 @@@myocardial ischemia-@@@@DISEASE_Reperfusion_Injury @DISEASE_MESH:D015427 @@@reperfusion injury@@@ and cell pyroptosis via @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@/@GENE_DFNA34 @GENE_114548 @@@NLRP3@@@ inflammasome pathway", "citations": {"NLM": "Zhang J, Huang L, Shi X, Yang L, Hua F, Ma J, Zhu W, Liu X, Xuan R, Shen Y, Liu J, Lai X, Yu P. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway Aging (Albany NY). 2020 Nov 24;12(23):24270-24287. PMID: 33232283", "BibTeX": "@article{33232283, title={Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway}, author={Zhang J and Huang L and Shi X and Yang L and Hua F and Ma J and Zhu W and Liu X and Xuan R and Shen Y and Liu J and Lai X and Yu P}, journal={Aging (Albany NY)}, volume={12}, number={23}, pages={24270-24287}}"}}, {"_id": "37631036", "pmid": 37631036, "pmcid": "PMC10459572", "title": "Effects of Metformin on Ischemia/Reperfusion Injury: New Evidence and Mechanisms", "journal": "Pharmaceuticals (Basel)", "authors": ["Osorio-Llanes E", "Villamizar-Villamizar W", "Ospino Guerra MC", "Díaz-Ariza LA", "Castiblanco-Arroyave SC", "Medrano L", "Mengual D", "Belón R", "Castellar-López J", "Sepúlveda Y", "Vásquez-Trincado C", "Chang AY", "Bolívar S", "Mendoza-Torres E"], "date": "2023-08-09T00:00:00Z", "doi": "10.3390/ph16081121", "meta_date_publication": "2023 Aug 9", "meta_volume": "16", "meta_issue": "8", "meta_pages": "", "score": 50250.613, "text_hl": "...2. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@", "citations": {"NLM": "Osorio-Llanes E, Villamizar-Villamizar W, Ospino Guerra MC, Díaz-Ariza LA, Castiblanco-Arroyave SC, Medrano L, Mengual D, Belón R, Castellar-López J, Sepúlveda Y, Vásquez-Trincado C, Chang AY, Bolívar S, Mendoza-Torres E. Effects of Metformin on Ischemia/Reperfusion Injury: New Evidence and Mechanisms Pharmaceuticals (Basel). 2023 Aug 9;16(8):. PMID: 37631036", "BibTeX": "@article{37631036, title={Effects of Metformin on Ischemia/Reperfusion Injury: New Evidence and Mechanisms}, author={Osorio-Llanes E and Villamizar-Villamizar W and Ospino Guerra MC and Díaz-Ariza LA and Castiblanco-Arroyave SC and Medrano L and Mengual D and Belón R and Castellar-López J and Sepúlveda Y and Vásquez-Trincado C and Chang AY and Bolívar S and Mendoza-Torres E}, journal={Pharmaceuticals (Basel)}, volume={16}, number={8}}"}}, {"_id": "33019635", "pmid": 33019635, "pmcid": "PMC7600544", "title": "Comparison of Effects of Metformin, Phenformin, and Inhibitors of Mitochondrial Complex I on Mitochondrial Permeability Transition and Ischemic Brain Injury", "journal": "Biomolecules", "authors": ["Skemiene K", "Rekuviene E", "Jekabsone A", "Cizas P", "Morkuniene R", "Borutaite V"], "date": "2020-10-01T00:00:00Z", "doi": "10.3390/biom10101400", "meta_date_publication": "2020 Oct 1", "meta_volume": "10", "meta_issue": "10", "meta_pages": "", "score": 50246.258, "text_hl": "The data suggest that, depending on the age, @CHEMICAL_Phenformin @CHEMICAL_MESH:D010629 @@@phenformin@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may protect the brain against @<m>DISEASE_Myocardial_Ischemia</m> @DISEASE_MESH:D017202 @@@ischemic damage@@@ possibly by suppressing MPTP via inhibition of mitochondrial Complex I.", "citations": {"NLM": "Skemiene K, Rekuviene E, Jekabsone A, Cizas P, Morkuniene R, Borutaite V. Comparison of Effects of Metformin, Phenformin, and Inhibitors of Mitochondrial Complex I on Mitochondrial Permeability Transition and Ischemic Brain Injury Biomolecules. 2020 Oct 1;10(10):. PMID: 33019635", "BibTeX": "@article{33019635, title={Comparison of Effects of Metformin, Phenformin, and Inhibitors of Mitochondrial Complex I on Mitochondrial Permeability Transition and Ischemic Brain Injury}, author={Skemiene K and Rekuviene E and Jekabsone A and Cizas P and Morkuniene R and Borutaite V}, journal={Biomolecules}, volume={10}, number={10}}"}}, {"_id": "40306606", "pmid": 40306606, "title": "AMPK mediates the anti-ferroptosis effect of acupuncture in cerebral ischemia-reperfusion rats.", "journal": "Brain Res", "authors": ["Wang R", "Xu JF"], "date": "2025-04-28T00:00:00Z", "doi": "10.1016/j.brainres.2025.149662", "meta_date_publication": "2025 Apr 28", "meta_volume": "", "meta_issue": "", "meta_pages": "149662", "score": 50231.8, "text_hl": "Further studies showed that acupuncture reduced the levels of Fe2+, @CHEMICAL_3_4_Methylenedioxyamphetamine @CHEMICAL_MESH:D015104 @@@MDA@@@ and the expression of @GENE_TFRC @GENE_64678 @@@TFR1@@@ protein and increased the expression of @GENE_SLC7A11 @GENE_310392 @@@SLC7A11@@@ and @GENE_GPX4 @GENE_29328 @@@GPX4@@@ protein in the diseased hippocampal region of MCAO/R @SPECIES_10116 @@@rats@@@. In addition, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, as an @GENE_PRKAA2 @GENE_78975 @@@AMPK@@@ activator, significantly enhanced the protective effect of acupuncture on @<m>DISEASE_Myocardial_Ischemia</m> @DISEASE_MESH:D017202 @@@cerebral ischemic injury@@@ and enhanced the acupuncture-mediated reduction of Fe2+, @CHEMICAL_3_4_Methylenedioxyamphetamine @CHEMICAL_MESH:D015104 @@@MDA@@@ levels and @GENE_TFRC @GENE_64678 @@@TFR1@@@ protein expression and the increase of @GENE_SLC7A11 @GENE_310392 @@@SLC7A11@@@ and @GENE_GPX4 @GENE_29328 @@@GPX4@@@ protein expression in the lesioned hippocampal region of MCAO/R @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Wang R, Xu JF. AMPK mediates the anti-ferroptosis effect of acupuncture in cerebral ischemia-reperfusion rats. Brain Res. 2025 Apr 28;():149662. PMID: 40306606", "BibTeX": "@article{40306606, title={AMPK mediates the anti-ferroptosis effect of acupuncture in cerebral ischemia-reperfusion rats.}, author={Wang R and Xu JF}, journal={Brain Res}, pages={149662}}"}}, {"_id": "34621312", "pmid": 34621312, "pmcid": "PMC8492251", "title": "Impact of Novel Guidelines on Multifactorial Control and Its Association with Mortality in Adult Patients with Hypertension and Newly Diagnosed Type 2 Diabetes: A 4-Year Prospective Multicenter Study", "journal": "Int J Endocrinol", "authors": ["Nguyen NT", "Chau HN", "Le NH", "Nguyen HH", "Nguyen HA"], "date": "2021-09-28T00:00:00Z", "doi": "10.1155/2021/9977840", "meta_date_publication": "2021", "meta_volume": "2021", "meta_issue": "", "meta_pages": "9977840", "score": 50227.258, "text_hl": "Renin-angiotensin-aldosterone inhibitor, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, and statin were prescribed in 89.8%, 66.3%, and 67.1%. ", "citations": {"NLM": "Nguyen NT, Chau HN, Le NH, Nguyen HH, Nguyen HA. Impact of Novel Guidelines on Multifactorial Control and Its Association with Mortality in Adult Patients with Hypertension and Newly Diagnosed Type 2 Diabetes: A 4-Year Prospective Multicenter Study Int J Endocrinol. 2021;2021():9977840. PMID: 34621312", "BibTeX": "@article{34621312, title={Impact of Novel Guidelines on Multifactorial Control and Its Association with Mortality in Adult Patients with Hypertension and Newly Diagnosed Type 2 Diabetes: A 4-Year Prospective Multicenter Study}, author={Nguyen NT and Chau HN and Le NH and Nguyen HH and Nguyen HA}, journal={Int J Endocrinol}, volume={2021}, pages={9977840}}"}}, {"_id": "18080084", "pmid": 18080084, "title": "Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening.", "journal": "Basic Res Cardiol", "authors": ["Bhamra GS", "Hausenloy DJ", "Davidson SM", "Carr RD", "Paiva M", "Wynne AM", "Mocanu MM", "Yellon DM"], "date": "2008-05-01T00:00:00Z", "doi": "10.1007/s00395-007-0691-y", "meta_date_publication": "2008 May", "meta_volume": "103", "meta_issue": "3", "meta_pages": "274-84", "score": 50059.26, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ protects the @<m>DISEASE_Myocardial_Ischemia</m> @DISEASE_MESH:D017202 @@@ischemic heart@@@ by the @GENE_AKT1 @GENE_24185 @@@Akt@@@-mediated inhibition of mitochondrial permeability transition pore opening.", "citations": {"NLM": "Bhamra GS, Hausenloy DJ, Davidson SM, Carr RD, Paiva M, Wynne AM, Mocanu MM, Yellon DM. Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening. Basic Res Cardiol. 2008 May;103(3):274-84. PMID: 18080084", "BibTeX": "@article{18080084, title={Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening.}, author={Bhamra GS and Hausenloy DJ and Davidson SM and Carr RD and Paiva M and Wynne AM and Mocanu MM and Yellon DM}, journal={Basic Res Cardiol}, volume={103}, number={3}, pages={274-84}}"}}, {"_id": "29165830", "pmid": 29165830, "title": "Possible protective mechanisms exerted by metformin or metformin and vitamin E in isoproterenol-induced cardiac injury.", "journal": "J Cell Biochem", "authors": ["Al-Rasheed NM", "Al-Rasheed NM", "Al-Rabeeah DA", "Al-Barrak HS", "Al-Salman SA", "Ibrahim SA", "Al-Hassab SA", "Al-Amin MA", "Hasan IH", "Al-Ajmi HN", "Al-Shammari TK"], "date": "2018-05-01T00:00:00Z", "doi": "10.1002/jcb.26530", "meta_date_publication": "2018 May", "meta_volume": "119", "meta_issue": "5", "meta_pages": "3903-3912", "score": 50055.45, "text_hl": "Several studies have reported that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is cardioprotective for @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ and non-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @<m>DISEASE_Myocardial_Ischemia</m> @DISEASE_MESH:D017202 @@@ischemic hearts@@@ through mechanisms that cannot be entirely attributed to its anti-@DISEASE_Hyperglycemic_Hyperosmolar_Nonketotic_Coma @DISEASE_MESH:D006944 @@@hyperglycemic@@@ effect. ", "citations": {"NLM": "Al-Rasheed NM, Al-Rasheed NM, Al-Rabeeah DA, Al-Barrak HS, Al-Salman SA, Ibrahim SA, Al-Hassab SA, Al-Amin MA, Hasan IH, Al-Ajmi HN, Al-Shammari TK. Possible protective mechanisms exerted by metformin or metformin and vitamin E in isoproterenol-induced cardiac injury. J Cell Biochem. 2018 May;119(5):3903-3912. PMID: 29165830", "BibTeX": "@article{29165830, title={Possible protective mechanisms exerted by metformin or metformin and vitamin E in isoproterenol-induced cardiac injury.}, author={Al-Rasheed NM and Al-Rasheed NM and Al-Rabeeah DA and Al-Barrak HS and Al-Salman SA and Ibrahim SA and Al-Hassab SA and Al-Amin MA and Hasan IH and Al-Ajmi HN and Al-Shammari TK}, journal={J Cell Biochem}, volume={119}, number={5}, pages={3903-3912}}"}}, {"_id": "23423523", "pmid": 23423523, "title": "Metformin therapy in diabetes: the role of cardioprotection.", "journal": "Curr Atheroscler Rep", "authors": ["El Messaoudi S", "Rongen GA", "Riksen NP"], "date": "2013-04-01T00:00:00Z", "doi": "10.1007/s11883-013-0314-z", "meta_date_publication": "2013 Apr", "meta_volume": "15", "meta_issue": "4", "meta_pages": "314", "score": 50055.26, "text_hl": "Consequently, treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ might potentially improve cardiovascular outcome in @SPECIES_9606 @@@patients@@@ at risk for @<m>DISEASE_Myocardial_Ischemia</m> @DISEASE_MESH:D017202 @@@myocardial ischemia@@@, even if these @SPECIES_9606 @@@patients@@@ do not have @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@. ", "citations": {"NLM": "El Messaoudi S, Rongen GA, Riksen NP. Metformin therapy in diabetes: the role of cardioprotection. Curr Atheroscler Rep. 2013 Apr;15(4):314. PMID: 23423523", "BibTeX": "@article{23423523, title={Metformin therapy in diabetes: the role of cardioprotection.}, author={El Messaoudi S and Rongen GA and Riksen NP}, journal={Curr Atheroscler Rep}, volume={15}, number={4}, pages={314}}"}}, {"_id": "27074768", "pmid": 27074768, "title": "Comparative Impact of Hypoglycemic Agents on Severity and Extent of Myocardial Ischemia in Patients With Type 2 Diabetes Mellitus Undergoing Myocardial Perfusion Scintigraphy.", "journal": "J Cardiovasc Pharmacol", "authors": ["Biondi-Zoccai G", "Pinto A", "Versaci F", "Procaccini E", "Neri G", "Sesti G", "Uccioli L", "Vetere M", "Peruzzi M", "Nudi F"], "date": "2016-08-01T00:00:00Z", "doi": "10.1097/FJC.0000000000000399", "meta_date_publication": "2016 Aug", "meta_volume": "68", "meta_issue": "2", "meta_pages": "162-70", "score": 50053.47, "text_hl": "Unadjusted analyses and analyses adjusting for baseline features suggested that @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulfonylureas@@@ alone or in combination were associated with more severe @DISEASE_Ischemia @DISEASE_MESH:D007511 @@@ischemia@@@ than nonsulfonylurea regimens (P < 0.05), whereas combination regimens including @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ were associated with more extensive @<m>DISEASE_Myocardial_Ischemia</m> @DISEASE_MESH:D017202 @@@myocardial ischemia@@@ than the other regimens (P < 0.05 for both). ", "citations": {"NLM": "Biondi-Zoccai G, Pinto A, Versaci F, Procaccini E, Neri G, Sesti G, Uccioli L, Vetere M, Peruzzi M, Nudi F. Comparative Impact of Hypoglycemic Agents on Severity and Extent of Myocardial Ischemia in Patients With Type 2 Diabetes Mellitus Undergoing Myocardial Perfusion Scintigraphy. J Cardiovasc Pharmacol. 2016 Aug;68(2):162-70. PMID: 27074768", "BibTeX": "@article{27074768, title={Comparative Impact of Hypoglycemic Agents on Severity and Extent of Myocardial Ischemia in Patients With Type 2 Diabetes Mellitus Undergoing Myocardial Perfusion Scintigraphy.}, author={Biondi-Zoccai G and Pinto A and Versaci F and Procaccini E and Neri G and Sesti G and Uccioli L and Vetere M and Peruzzi M and Nudi F}, journal={J Cardiovasc Pharmacol}, volume={68}, number={2}, pages={162-70}}"}}]}